Prices, pipelines and patent cliffs: Inside pharma's big reset [CNBC]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: CNBC
Instead, drugmakers looked ahead, with 2026 shaping up to be a defining year following a dramatic 2025, and one where the impact from last year's developments is set to crystallize. “2025 was about understanding kind of the rules of the future of the game… what's still to be seen in [2026] is how those companies actually implement what they agreed to, particularly in the deals that you saw with the Trump administration,” McKinsey Senior Partner Greg Graves told CNBC. In addition to political dealings, companies are facing a so-called “patent cliff” in the upcoming years, where some of the world's best-selling drugs lose exclusivity in key markets, exposing them to competition from much cheaper generics. Pipelines are key – and companies know it While drugmakers are always to some extent touting their pipelines , they're now putting them even more on display as they seek to reassure investors that their pipeline holds enough promise to offset upcoming patent expiries. “With
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Analysis-Sanofi's new CEO needs to fix drug pipeline and navigate Trump [Yahoo! Finance Canada]Yahoo! Finance Canada
- Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued [Seeking Alpha]Seeking Alpha
- Sanofi replaces CEO Paul Hudson with outgoing Merck KGaA head [Yahoo! Finance]Yahoo! Finance
- How founders can tap women investors as a competitive advantage in 2026 [Fortune]Fortune
- Does Sanofi's CEO Overhaul And Governance Shift Change The Bull Case For Sanofi (ENXTPA:SAN)? [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 2/12/26 - Form 6-K
- 2/11/26 - Form 13F-HR
- 2/10/26 - Form 6-K
- SNY's page on the SEC website